Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 30Observational 1

Sponsor

Cancer Type

Breast 7Gastrointestinal 6Genitourinary 5Plasma cell 4Thoracic 2Other hematologic neoplasm 2Lymphoid 2Dermatologic 2Tumor-Agnostic 1Sarcoma 1Myeloid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Ovarian Neoplasms 1Kenny-Caffey syndrome, Type 1 1Fallopian Tube Neoplasms 1

Interventions

Surveys and Questionnaires 58Blood Specimen Collection 31Surgical Procedures, Operative 13Interviews as Topic 13Immunohistochemistry 13Data Collection 13niraparib 12Hyperthermic Intraperitoneal Chemotherapy 11Observation 10Drug Therapy 10Cytoreduction Surgical Procedures 10Magnetic Resonance Spectroscopy 9Radiotherapy 8Polymerase Chain Reaction 8Papanicolaou Test 8Colposcopy 8Cisplatin 8Biopsy 8Amplified Fragment Length Polymorphism Analysis 8olaparib 7Carboplatin 7Ultrasonography 6Sentinel Lymph Node Biopsy 6Psychiatric Rehabilitation 6Paclitaxel 6Microarray Analysis 6Laparoscopy 6Hysterectomy 6DNA Methylation 6liposomal doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Standard of Care × Gynecologic × Clear all
NCT05574673 2026-02-27

HERO

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Recruiting
1,000 enrolled
Gynecologic

Kenny-Caffey syndrome, Type 1, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡